Well, I wasn,t sure if GSK were still hiding figures or not, but this release of 92 million pounds, appears to be the true figures, now ask yourself.................how come last quarter there was NIL to the USA and suddenly 3 months later 44 Million as been produced,? and they made a delivery at the end of March, so where did all this Relenza come from? gsk DIDN,T HAVE THE CAPACITY TO PRODUCE IT? they employed an outside party to make the bulk Zanamivir in the US and then quickly off to the factory in North Carolina, to be put in Inhalers and packaged off to the US Government...........I found the purchase orders with delivery dates. TJW found the API producer.
It only confirms to me another clue, that a settlement is underway. The question is when will it be released?
Probably won,t be this week, Biota will let this news make an impact.
Then we have Lani under application in Japan/Asia by Sankyo, don,t forget this is 50% to Biota and the market is as big as the US.............Very large Seasonal market. Good times have arrived for Biota.
Cheers dma
- Forums
- ASX - By Stock
- BTA
- right on cue announcement
right on cue announcement, page-8
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
SS1
SUN SILVER LIMITED
Gerard O'Donovan, Executive Director
Gerard O'Donovan
Executive Director
SPONSORED BY The Market Online